ACVR2B Recombinant Protein: A Core Type II Receptor for TGF-β Superfamily Signal Transduction

Author: Senior Product Manager of UA Views：6

This article focuses on the molecular characteristics and signal transduction functions of activin receptor type IIB (ACVR2B), systematically elaborating its domain composition and tissue expression distribution as a type II serine/threonine kinase receptor of the TGF-β superfamily, analyzing the molecular mechanisms by which it forms heterodimeric complexes with type I receptors to mediate the intracellular transmission of activin signals, and exploring the differential roles of the canonical SMAD2/3 pathway and non-canonical MAPK, SMAD1/5/8, and NOX4-ROS pathways under conditions of muscle development, neural function, and pathology.

Recent Advances
Product Information

Recent Advances

ACVR2B Recombinant Protein: A Core Type II Receptor for TGF-β Superfamily Signal Transduction

Summary: This article focuses on the molecular characteristics and signal transduction functions of activin receptor type IIB (ACVR2B), systematically describing its domain composition and tissue expression distribution as a type II serine/threonine kinase receptor of the TGF-β superfamily, analyzing the molecular mechanism by which it forms heterodimeric complexes with type I receptors to mediate the intracellular transmission of activin signals, and discussing the differential roles of the canonical SMAD2/3 pathway and the non-canonical MAPK, SMAD1/5/8, and NOX4-ROS pathways in muscle development, neural function, and pathological conditions.

I. Molecular Characteristics and Tissue Expression Distribution of ACVR2B.

The type 2B serine/threonine kinase receptor is a type II transmembrane protein. ACVR2B is activin A receptor type 2B, belonging to the type II receptor serine/threonine kinases of the TGF-β superfamily. ACVR2B is widely distributed in a variety of tissues, with prominent expression in the brain, testes, and muscle, and exhibits cross-species conservation. Its expression level is closely related to the affinity for ligands such as activin and to downstream signal regulation, and it plays a key role especially in muscle development and neural function. This concentrated expression in neural, reproductive, and muscle tissues is highly consistent with its functional localization in neuronal differentiation and survival, pituitary hormone secretion, and muscle mass regulation, and also suggests that this receptor undertakes an irreplaceable role as a signaling hub in multiple physiological systems.

II. Protein Structure and Receptor Complex Assembly of ACVR2B.

ACVR2B is a type II serine/threonine kinase receptor transmembrane protein encoded by the ACVR2B gene, with a length of 512 amino acids and a molecular weight of approximately 57.7 kDa, comprising extracellular, transmembrane, and intracellular domains. The extracellular domain has a characteristic ligand-binding domain that specifically recognizes ligands such as activin A/B and inhibin A. The intracellular kinase domain contains conserved serine/threonine kinase activity and can phosphorylate type I receptors such as ACVR1B. Regarding receptor complex formation, ACVR2B needs to form a heterodimeric complex with type I receptors to initiate downstream signal transduction. In this complex, ACVR2B is the main ligand-binding receptor, responsible for recognizing activin A/B and inhibin A, while the type I receptor is responsible for downstream signal transduction. This division of labor, in which "the type II receptor recognizes the ligand and the type I receptor transmits the signal," is the common structural logic of the TGF-β superfamily receptor system.

III. The Canonical SMAD2/3 Signaling Pathway Mediated by ACVR2B.

ACVR2B is a transmembrane serine/threonine kinase receptor whose main function is to bind with type I receptors to form a complex and mediate the transmission of activin signals from the cell membrane into the cell. This signaling pathway regulates a variety of key physiological processes, including neuronal differentiation and survival, hair follicle development, pituitary follicle-stimulating hormone secretion, wound healing, immune suppression, carcinogenesis, and ovarian follicle development. In terms of the specific steps of signal transmission, activin binding to ACVR2B activates its kinase activity, which then phosphorylates and activates the type I receptor; the activated type I receptor subsequently phosphorylates serine residues at the C-terminus of SMAD2/3 proteins; phosphorylated SMAD2/3 dissociates from the receptor, forms a complex with SMAD4 in the cytoplasm, and is transported into the nucleus, ultimately mediating activin-induced gene transcription. In muscle tissue, this pathway regulates the expression of myogenic genes such as MyoD and Myogenin, affecting cell differentiation, proliferation, or hypertrophy, and is the core mechanism of negative regulation of muscle mass.

IV. Dual Regulatory Mechanisms of ACVR2B Signaling.

ACVR2B signaling is subject to dual regulation. The first is inhibitory SMAD7: it is recruited to ACVR1B through FKBP1A, preventing SMAD2/3 from binding to the receptor, thereby blocking signal transmission at the proximal end of the receptor. The second is inhibin B: it binds to ACVR2B through the co-receptor IGSF1, antagonizing activin signal transduction and achieving competitive inhibition at the level of ligand recognition. These two regulatory pathways act at different nodes of the signaling pathway, jointly ensuring that the intensity of activin signaling is precisely limited and avoiding pathological consequences such as muscle atrophy or heterotopic ossification caused by excessive activation.

V. Non-Canonical Signaling Pathways and Pathological Significance of ACVR2B.

In addition to the canonical SMAD2/3 pathway, ACVR2B can also transmit signals through multiple non-canonical pathways. In the MAPK pathway, ACVR2B can transmit signals independently of SMAD by activating ERK and p38, participating in cellular stress responses and migration. In the SMAD1/5/8 pathway, under pathological conditions such as fibrodysplasia ossificans progressiva, ACVR2B binds to mutant ALK2, abnormally activating SMAD1/5/8 and leading to heterotopic ossification. In the NOX4-ROS axis, in osteoarthritis, the activin A-ACVR2B axis amplifies SMAD2/3 signaling by activating NADPH oxidase 4 to produce reactive oxygen species, exacerbating cartilage destruction. The discovery of these non-canonical pathways indicates that the functional spectrum of ACVR2B far exceeds a single SMAD2/3 signaling axis, and its signal output in different tissues and pathological contexts has significant contextual dependence.

VI. Conclusion.

In basic research and drug development related to ACVR2B, high-quality recombinant ACVR2B protein is a core tool for dissecting its binding mechanism with activin ligands and evaluating the activity of targeted drugs. The GST tag facilitates efficient purification by glutathione affinity chromatography and can serve as a detection tag for analyses such as enzyme-linked immunosorbent assay and surface plasmon resonance. To meet the needs of ACVR2B functional research and signaling pathway mechanism exploration, Ulab provides ACVR2B GST Tag Protein, Human. This product is suitable for applications such as binding activity analysis of ACVR2B with activin A/B and inhibin A, research on the mechanism of heterodimerization of ACVR2B with type I receptors, in vitro evaluation of SMAD2/3 signaling pathway activation, and screening of antibodies or ligand trap drugs targeting ACVR2B.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next